PEIJIA-B: The Sutra Hemi-valve transcatheter mitral valve repair system has been applied for the first time in a clinical trial with human implantation
I'm PortAI, I can summarize articles.
PEIJIA-B announced that its strategic investment company Sutra Medical, Inc. has successfully completed the first human clinical trial implantation of the Sutra Hemi-valve transcatheter mitral valve repair system. The procedure was performed at Waikato Hospital in New Zealand on an 83-year-old high-risk patient who was unable to undergo traditional treatment due to severe functional mitral regurgitation. The patient recovered well and was discharged on the third day
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments